clinical research

inter

plantmedicine

poster sessions

 

New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community.
Los Angeles Times, September 2015

Discover the latest research into the benefits and risks of psychedelics and marijuana for psychotherapy, neuroscience, spirituality, and creativity, and more.

The Three-Day Conference (April 21-23) will feature three simultaneous tracks of presentations by leading and up-and-coming international researchers in the multidisciplinary field of psychedelic science and medicine. Presenters from around the world will share recently completed and ongoing research into the therapeutic, scientific, and spiritual uses of:

  • MDMA
  • LSD
  • Ayahuasca
  • Psilocybin
  • Ibogaine
  • Ketamine
  • Peyote
  • Medical marijuana
...and much more!

 

 

Clinical Research Track

 

 


 


 


 


aliciadanforth

 


Rick Doblin, Ph.D.
The Future of Psychedelic Therapy

 


 


 


 


 


 


 


 


 


Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N.
MDMA-Assisted Psychotherapy for PTSD: Lessons from Phase 2 Clinical Trials
CE

 


David Nichols, Ph.D.
Psychedelic Neuroscience
CE

 


David Nutt, D.M., F.R.C.P., F.R.C.Psych, F.Med.Sci.
Psychedelic Research: From Brain Imaging to Policy Reform

 


 


Marcela Ot'alora, M.A., L.P.C. and Bruce Poulter, R.N., M.P.H.
MDMA as Profound Change Agent: Insights from MDMA-assisted Psychotherapy for PTSD Research

 


 


 


 


 


Ben Sessa, M.B.B.S., M.D., B.Sc., M.R.C.Psych.
MDMA Therapy: A Child Psychiatrist's Perspective
CE

 


 


 


Phil Wolfson M.D. and Julane Andries L.M.F.T.
MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness
CECME

 


 

 

Interdisciplinary Research Track

 

 


 


 


 


 


 


 


 


 


 


phil wolfson
chadi abdallah
richard roston
alison mcinnes

Phil Wolfson, M.D., Chadi G. Abdallah, M.D., Richard Roston, M.D., and Alison McInnes, M.D.
PANEL: Ketamine in Clinical Practice: Varieties, Research, and Opportunities

 


Katherine Hendy, Ph.D.
The Placebo Paradox

 


Monnica T. Williams, Ph.D., A.B.P.P., Jae Sevelius, Ph.D., and Ismail Ali, J.D.
PANEL: Psychedelics, Injustice, and the Intersectionality of Trauma

 



Stanley Krippner, Ph.D.
Remembering Salvador Roquet
CE


philippe lucas sue sisley zach walsh

Philippe Lucas, M.A., Suzanne Sisley, M.D, Zach Walsh, Ph.D.
PANEL: Marijuana for PTSD

 


Ethan Nadelmann, Ph.D.
Drug Policy and Psychedelics

 


 


 


 


 


 


 


Sara Gael, M.A., Richard Gottlieb, R.N., Stefanie Jones, Katherine MacLean, Ph.D., Maria Carmo Carvalho
PANEL: Psychedelic Harm Reduction: Creating the Container

 


 


 


 


 


 


 


 


Plant Medicine Track

Organized by Bia Labate, Ph.D.

 


 


 


 


 


 


 


 


 


 


alexander dawson headshot

Alexander Dawson, Ph.D.
Peyote's Race Problem
CE

 


 


 


 


 


 


 


 


 


 


 


o hayden griffin

O. Hayden Griffin, III, Ph.D.
The Therapeutic Potential of Kratom
CE

 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


graham st john

Graham St. John, Ph.D.
DMT, Liminality, and Hyperspace

 


 


 


 


 


 

MORE SPEAKERS COMING SOON

Share This Page